L. Roy Papp & Associates’s Pediatrix Medical MD Stock Holding History

L. Roy Papp & Associates’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-11,422	Closed	-$792K	–	155
2017 Q1	$792K	Hold	11,422	–	–	0.18%	87
2016 Q4	$761K	Sell	11,422 -61	-0.5%	-$3.97K	0.17%	92
2016 Q3	$761K	Hold	11,483	–	–	0.18%	90
2016 Q2	$832K	Buy	11,483 +1,245	+12%	+$85.6K	0.2%	90
2016 Q1	$662K	Hold	10,238	–	–	0.16%	97
2015 Q4	$734K	Buy	10,238 +1,500	+17%	+$111K	0.18%	89
2015 Q3	$671K	Buy	8,738 +2,283	+35%	+$184K	0.17%	92
2015 Q2	$478K	Buy	+6,455	New	+$465K	0.11%	107

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

L. Roy Papp & Associates's MD Position: Q2 2017 in Review

L. Roy Papp & Associates sold out of Pediatrix Medical (MD) in Q2 2017, closing a stake of 11,422 shares — an estimated $792K sold.

L. Roy Papp & Associates first reported a position in MD in Q2 2015 and held it in 8 quarters. The position peaked at $832K in Q2 2016. 332 funds tracked by Wall St. Rank hold MD as of Q2 2017.

L. Roy Papp & Associates reported no remaining Pediatrix Medical position as of Q2 2017 after selling out during the quarter.
L. Roy Papp & Associates sold 11,422 Pediatrix Medical shares in Q2 2017, an estimated $792K.
L. Roy Papp & Associates first reported a position in Pediatrix Medical in Q2 2015 and held it in 8 quarters.
L. Roy Papp & Associates's Pediatrix Medical position peaked at $832K in Q2 2016.
332 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2017.

Based on L. Roy Papp & Associates's 13F filing for Q2 2017, filed 28 Jul 2017.